Alesta Therapeutics News and Resources

Alesta Therapeutics, a biotechnology company focused on small molecule therapies for rare diseases, has announced the successful closing of a €65 million Series A financing round. The oversubscribed round was co-led by Frazier Life Sciences and Droia Ventures, with additional